A comparison of colistin versus colistin plus meropenem for the treatment of carbapenem-resistant acinetobacter baumannii in critically ill patients: A propensity score-matched analysis

• المؤلفون الرئيسيون: Wasan Katip, Suriyon Uitrakul, Peninnah Oberdorfer
• التنسيق: دورية
• منشور في: 2020
• الموضوعات: Biochemistry, Genetics and Molecular Biology; Immunology and Microbiology; Medicine; Pharmacology, Toxicology and Pharmaceutics
• الوصول للمادة أونلاين: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85091722159&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/70164

© 2020 by the authors. Licensee MDPI, Basel, Switzerland. Carbapenem-resistant Acinetobacter baumannii (CRAB), an important nosocomial pathogen, occurs particularly in the intensive care unit (ICU). Thus, the aim of this study was to compare the efficacy and safety of documented treatment with colis...